loading...
Welcome, You're signed in as: {{credentials.userName}}
But you still need to activate your account.
But you still need to activate your account.
WASHINGTON – The maker of a popular new treatment for women’s irritable bowel syndrome pulled the drug Lotronex off the market Tuesday after it was linked to a growing number of deaths and hospitalizations. The withdrawal by Glaxo Wellcome Inc. comes just nine months after…
Sign in or Subscribe to view this content.
Sign in or Subscribe to view this content.
WASHINGTON – The maker of a popular new treatment for women’s irritable bowel syndrome pulled the drug Lotronex off the market Tuesday after it was linked to a growing number of deaths and hospitalizations.
The withdrawal by Glaxo Wellcome Inc. comes just nine months after Lotronex began selling with great fanfare.
The problem: Lotronex can cause severe side effects, including a life-threatening intestinal inflammation called ischemic colitis.
Comments
comments for this post are closed